|
| 1 |
Predictive Factors for Rheumatoid Arthritis Flare After Switching From Intravenous to Subcutaneous Formulation of Tocilizumab in Real-World Practice
Soo Min Ahn, Ji Seon Oh, Hyun Mi Heo, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim
|
|
| 2 |
A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still’s Disease With Tocilizumab
Ju Ho Lee, You-Jung Ha, Eun Ha Kang, Sung Hae Chang, Yun Jong Lee, sup, 3, sup
J Rheum Dis.2022;29(2):123-128. Published online 2022 April 1
DOI: http://dx.doi.org/10.4078/jrd.2022.29.2.123
|
|
| 3 |
Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study
Jina Yeo, Han Joo Baek, Yeong Wook Song, Eun Young Lee
|
|
| 4 |
1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis
Haneul Kim, Seungye Baek, Seung-Min Hong, Jaeseon Lee, Seung Min Jung, Jennifer Lee, Mi-La Cho, Seung-Ki Kwok, Sung-Hwan Park
|
|
| 5 |
Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience
Sung Soo Ahn, Seung Min Jung, Jason Jungsik Song, Yong-Beom Park, Jun Yong Park, Sang-Won Lee
Yonsei Med J.2018;59(3):452-456. Published online 2018 March 30
DOI: http://dx.doi.org/10.3349/ymj.2018.59.3.452
|
|
| 6 |
Clinical and Hematological Effects of Tocilizumab on Serum Hepcidin, Anemia Response and Disease Activity in Patients with Active Rheumatoid Arthritis
Ki-Jeong Park, Hye-Mi Jin, Young-Nan Cho, Jeong-Hwa Kang, Hyun-Ju Jung, Ji-Hyoun Kang, Ji-Eun Kim, Yi-Rang Yim, Jeong-Won Lee, Kyung-Eun Lee, Dong-Jin Park, Tae-Jong Kim, Shin-Seok Lee, Seung-Jung Kee, Yong-Wook Park
J Rheum Dis.2016;23(1):37-46. Published online 2016 October 31
DOI: http://dx.doi.org/10.4078/jrd.2016.23.1.37
|
|
| 7 |
A Case of Sepsis Caused by Cellulitis in a Patient with Rheumatoid Arthritis after Tocilizumab Treatment
Min Seok Yoo, Ji Sang Park, Yoon Suk Park, Hye Won Kim, Jin-Wuk Hur
J Rheum Dis.2016;23(1):55-60. Published online 2016 October 31
DOI: http://dx.doi.org/10.4078/jrd.2016.23.1.55
|
|
| 8 |
Tocilizumab-induced Transaminitis in a Seropositive Rheumatoid Arthritis Patient with Macrophage Activation Syndrome
Byung-woo Yoo, Cheol Keun Park, Hae Ryong Yun, Daehoon Kim, Soo-Kon Lee, Sang-Won Lee
Ewha Med J.2016;39(1):23-27. Published online 2016 January 29
DOI: http://dx.doi.org/10.12771/emj.2016.39.1.23
|
|
| 9 |
Appearance of Psoriasis after Tumor Necrosis Factor-α Blocker and Use of Ustekinumab or Tocilizumab for Refractory Monoarthritis
Jinyoung Moon, Nakwon Kwak, Jin Lim, Dong Jin Go, Jae Hyun Lee, Jin Kyun Park, Eun Bong Lee, Yeong Wook Song, Jai Il Youn, Eun Young Lee
J Rheum Dis.2015;22(4):263-268. Published online 2015 August 25
DOI: http://dx.doi.org/10.4078/jrd.2015.22.4.263
|
|
